SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-14-004137
Filing Date
2014-08-19
Accepted
2014-08-19 15:46:11
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1401585_10q.htm 10-Q 250162
2 EXHIBIT 31.1 t1401585_ex31-1.htm EX-31.1 8335
3 EXHIBIT 32.1 t1401585_ex32-1.htm EX-32.1 4544
  Complete submission text file 0001571049-14-004137.txt   3385055

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20140630.xml EX-101.INS 477213
5 XBRL SCHEMA FILE mrna-20140630.xsd EX-101.SCH 39744
6 XBRL CALCULATION FILE mrna-20140630_cal.xml EX-101.CAL 34503
7 XBRL DEFINITION FILE mrna-20140630_def.xml EX-101.DEF 99728
8 XBRL LABEL FILE mrna-20140630_lab.xml EX-101.LAB 327646
9 XBRL PRESENTATION FILE mrna-20140630_pre.xml EX-101.PRE 210014
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 141052011
SIC: 2834 Pharmaceutical Preparations